Lopende projecten
In dit overzicht vindt u informatie over lopende onderzoeken waarbij data van SHM worden gebruikt. De lijst is gefilterd en toont alleen projecten die beschikbaar zijn voor een breed publiek. Wilt u meer weten over de stand van zaken in een project of een overzicht van de laatste publicaties, bekijk dan de publicaties in ons jaarverslag.
Bekijk het laatste jaarverslag
| SHM nr. | Titel project | Auteur(s) |
| I20109 | Update on trends in incidence and risk factors of anal cancer in HIV-infected patients | J. Prins, H. de Vries, P. Reiss, F. Wit, C. Smit, R.P. van der Zee |
| I20108 | Determining factors associated with disproportional weight gain in people with HIV with suppressed viremia switching antiretroviral therapy to an INSTI and/or TAF-containing regimen |
P. Reiss, M. Verburgh, F. Wit, S. Verboeket, A. Boyd, M. van der Valk |
| I20107 | HIV in Gelderland: characteristics of the infected population and testing behaviour among general practitioners | N. Nijsten, O. Richel, C. van Jaarsveld, G. ter Beest, K. Grintjes, A. van Sighem, R. van der Bij, S. Ostendorf, P. Dielissen, M. van de Luijtgaarden, R. Hermsen, C. van der Starre |
| I19105 | Remaining barriers to advancing hepatitis C micro-elimination in the HIV/HCV co-infected population in the Netherlands | M. van der Valk M, C. Isfordink, J. Arends, C. Smit, A. Boyd |
| I19104 | Long-term clinical and virological outcomes in aging perinatally and behaviourally HIV-infected young adults in the Netherlands (12-30 years) | A. Weijsenfeld, C. Blokhuis, C. Smit, M. van der Valk, F. Wit, D. Pajkrt |
| I19100 | HIV treatment outcomes of transgender people versus the general HIV-positive population in the Netherlands |
C. Daans, E. Hoornenborg, M. den Heijer, |
| I17095 |
Evaluation of diagnosis, referral and treatment of acute HIV-1 infection at the Amsterdam STI clinic: trends over time |
De Bree G, Schim van der Loeff M, Dijkstra M, Prins M, Prins J, van Rooijen M, Hogewoning A, van Sighem AI |
| I17093 |
The impact of mutations on the effectiveness of abacavir/lamivudine/dolutegravir regimens prescribed in treatment-experienced patients (The M184V/I – DTG study) |
Olearo F, Kouyos R, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Baettig V, Cavassini M, Gayet-Ageron A, Scherrer A, Schmid P, Bucher HC, Günthard H, Böni J, DÁrmino A, Zazzi M, Bellecave P, Cazanave C, Daffau P, Rijnders B, Reiss P, Wit F, Calmy A |
| I17092 |
Impact of the Positive Sisters peer support program on health outcomes in HIV-positive migrant women in the Netherlands |
F. Cobelens, L. Darvey, M. Adhikari, S. Boender |
| I16091 |
Longitudinal virological outcomes and factors associated with virological failure in HIV infected young adults in the Netherlands 1996-2016 |
Weijsenfeld AM, Wit FWNM, Pajkrt D |
| I16072 |
Comparison of the occurence of HBV-related liver disease and (liver-related) mortality between patients with hepatitis B mono-infection and patients co-infected with hepatitis B and HIV in the Netherlands (HARMONIC 2) |
J.E. Arends, C.M. Richter, F.I. Lieveld, P. Reiss, C. Smit, M. Spaier, K.J. Erpecum, I.M. Hoepelman |
| I16060 |
Evaluation of dolutegravir use of the treatment of HIV in the Netherlands: focus on switchers and adverse events |
D. Burger, R. van Crevel, A. Brouwer, P. Bollen, J.E. Arends, C.S. Hakkers, I.M. Hoepelman, K. Brinkman, G.E.L. van den Berk, F.I. Wit |
| I16038 |
Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients: a multicentre cohort study |
P.H. Ward, W. van Bisen, C.H.S.B. van den Berg, B.J.A. Rijnders, K. Brinkman, J.W. Mulder, L.B.S. Gelinck, A.I.M. Hoepelman, F.W.N.M. Wit, D. van de Beek, J.M. Prins |
| I16011 |
Type of cART regimen and the risk for immune reconstitution and inflammatory syndrome in HIV-1 infected patients. Is integrase inhibitor use an independent risk factor? |
I.E.A. Wijting, C. Rokx, F.W.N.M. Wit, P. Reiss, B.J.A. Rijnders |
| I15142 |
Use of regular outpatient medication n HIV/HCV co-infected patients in the Netherlands |
E.J. Smolders, C. Smit, C.T.M.M. De Kanter, A.S.M. Dofferhoff, J.E. Arends, K. Brinkman, B. Rijnders, M. van der Valk, P. Reiss, D.M. Burger, on behalf of the ATHENA national HIV obsercational cohort |
| I15090 |
Fibrosis progression after acute HCV infection in HIV-infected individuals |
M. van de Valk, K.W. Kooij, A. Newsum, C. Smit, P. reiss, M. Prins, J. van der Meer, MOSAIC Study Group, SHM Werkgroep Hepatitis |
| I15066 |
Cost-effectiveness of HIV treatment and care in the Netherlands |
A. Verbon, B.E. Nichols, C. Boucher, S. Geerlings, P. Reiss, A. van Sighem, F.P. Kroon, M.J. Postma, K. Brinkman |
| I15065 | Comparison of the occurrence of severe HBV-related liver disease and (liver-related) mortality between patients with hepatitis B mono-infection and patients coinfected with hepatitis B and HIV in the Netherlands. (HARMONIC) | J.E. Arends, C. Richter, F.I. Lieveld, P. Reiss, C. Smit, M. Spanier, K.J. van Erpecum, I.M. Hoepelman |
| I15043 | Cost-effectiveness of the Adherence Improving self-Management Strategy (AIMS) in HIV-care: A model-based economic evaluation | M. de Bruin, J. Prins, E. Oberjé, M. Hiligsmann, S. Evers, L. Gras |
| I15040 | Monitoring recent HIV infection in the Netherlands: implementation of Recent Infection Testing Algorithm (RITA) into routine HIV surveillance | E. Op de Coul, G. de Bree, A. van Sighem, K. Brinkman, J. Prins, S. Jurriaans. |
| I15022 | Community viral load as a tool for HIV surveillance in the Netherlands and South Africa | E. Op de Coul, R. Bolijn, J. Heijne, A. van Sighem, M. Kretzschmar, HIV Behandelaar |
| I15021 |
Global resistance following virologic failure with tenofovir +NNRTI containing antiretroviral regimens: a retrospective multi-centre multi-cohort study and meta-analysis
|
C. Rokx, R. Gupta, B. Rijnders, B. Shafer, J. Gregson, M. Tang, R. Hamers, E. Raizes, K. Crawford, V. Marconi, A. Hill, M. Hosseinipour, N. Clumeck, P. Kanki, S. Lockman, T. Rinke de Wit, S. Hoffman, T. de Oliveira, C. Wallis, L. Morris, G. Hunt, D. Dunn, J.L. Blanco, H. Gunthard, Dr. Kumarasamy, P. Kaleebu, D. Pillay, C. Charpentier, D. Descamps, A. van Damme, K. Theys, R. Camacho, V. Calvez, L. Gras |
| I15004 | The impact of combinations of strategies for HIV prevention among men who have sex with men | M. Xiridu, A. van den Bosch, B. van Benthem, E. Op de Coul, A. van Sighem, I. Stolte |
| I14157 | Overlap between HIV and HCV networks among MSM with HIV/HCV coinfection | J. Vanhommerig, J. Schinkel, D. Bezemer, T. van de laar, A. van Sighem, C. Smit, M. Prins |
| I14145 | Evaluation of an evidence-based, Internet-supported self-help program for people living with HIV suffering from mild to moderate depressive symptoms | N. Garnefski, V. Kraaij, S. van Luenen |
| I14144 | Geographical Information System to determine high prevalence aeras of targeted screening and early case-finding | I. Joore, J. van Bergen, E. op de Coul, A. van Sighem, J. Prins, S. Geerlings |
| I14096 | Primary and recurrent venous thromboembolism in Hiv-1 (PREDICT study) | J. Borjas-Howard, B.J.A. Rijnders, C. Rokx, Y.I.G.V. Tichelaar, A. Verbon, K. Meijer |
| I14087 | Clinical experience with rilpivirine (KLII study) | E. Roelofsen, D.M. Burger, D.J. Touw, L.B.S. Gelinck, E.B. Wilms |
| I14067 | Predictive value of cardiovascular risk equations in the HIV-infected population receiving care in the Dutch HIV treatment centers | F. Wit, R. van Zoest, I. Vaartjes. L. Gras, J. Arends, P. Reiss |
| I14065 | Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients: Implications for screening strategies | G. Wandeler, A. Rauch, P. Reiss, C. Smit, M. van der Valk, J. Arends |
| I13120 | SPREAD Program 3.0 - Surveillance of transmission of HIV- drug resistace | A.M.J. Wensing, C.A.B. Boucher, K. Brinkman, J. van der Meer, I. van de Ende, C. Richter, E. Schippers, D. de Vries-Sluijs, J. Schinkel, C. Smit |
| I13051 | Barrières voor hiv-preventie, -testen en -zorg onder migranten (aMASE) | M. Prins, F. Zuure, J. Bil, F. Burns, J. del Amo |
| I13032 | Combined and Comparative Analysis of Virulence Trends Across Multiple Cohorts | L. Gras, F. de Wolf, J. Herbeck, V. Mueller |
| I12045 | A HIV-1 genome wide association study to identify viral determinants of HIV-1 plasma concentration (BEEHIVE) | F. de Wolf, B. Berkhout, M. Cornelissen, C. Fraser, P. Kellam, A. Gall, L. Gras, A. van Sighem |
| I10021 | Characteristics of HIV-1 transmission among men having sex with men in the Netherlands | O. Ratmann |
| I08115 | Proposal for collaboration and data exchange between HMF and RIVM for nation HIV/AIDS surveillance and data transfer to ECDC in the context of EU obligations for reporting on HIV/AIDS | E. op den Coul, F. de Wolf, M. van der Sande, A. van Sighem, J. Vlug |
| I05513 | HIV Resistance Response Database Initiative (RDI) | A. Revell |
| I04034 | The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) | P. Reiss |